Strategic cybersecurity Nova Leah offers a specialized cybersecurity risk management platform for medical device manufacturers and healthcare providers, presenting a target for cross-selling advanced monitoring and third-party risk tools to medical device OEMs, hospitals, and health systems.

Launch momentum Recent introduction of SelectEvaluate in October 2023 signals a growth phase and willingness to scale solutions; use this timing to approach organizations prioritizing third-party risk management and continuous monitoring in healthcare.

Industry validation Past funding and awards, including seed investment from Northwell Health venture arm and export awards, provide credibility with potential enterprise buyers seeking proven vendors in healthcare cybersecurity.

Geographic footprint Dual presence in Dundalk, Ireland and the United States offers a bridge to EU hospitals and US healthcare entities, enabling both cross-border sales motions and compliance-focused conversations around ISO/IEC 27001 aligned practices.

Financial signal Revenue is currently modest, suggesting a partnership approach with larger healthcare manufacturers and systems to scale deployments, leverage existing investor credibility, and pursue multi-year contracts for risk management platforms.